Search

Your search keyword '"Wagner, Bridget"' showing total 431 results

Search Constraints

Start Over You searched for: Author "Wagner, Bridget" Remove constraint Author: "Wagner, Bridget"
431 results on '"Wagner, Bridget"'

Search Results

1. Reference compounds for characterizing cellular injury in high-content cellular morphology assays

3. An expanded universe of cancer targets.

5. A general approach to identify cell-permeable and synthetic anti-CRISPR small molecules

6. FALCON systematically interrogates free fatty acid biology and identifies a novel mediator of lipotoxicity

12. Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms

13. Nuisance compounds in cellular assays

14. An expanded universe of cancer targets

16. Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

20. Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome

24. Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms

26. KD025 Is a Casein Kinase 2 Inhibitor That Protects Against Glucolipotoxicity in β-Cells.

28. A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis

29. Preserved DNA Damage Checkpoint Pathway Protects against Complications in Long-Standing Type 1 Diabetes

32. FALCON systematically interrogates free fatty acid biology and identifies a novel mediator of lipotoxicity

41. Reference compounds for characterizing cellular injury in high-content cellular morphology assays

49. Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis–Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial

Catalog

Books, media, physical & digital resources